BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Segal GM, Eschbach JW, Egrie JC, Stueve T, Adamson JW. The anemia of end-stage renal disease: Hematopoietic progenitor cell response. Kidney International 1988;33:983-8. [DOI: 10.1038/ki.1988.97] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 1989;35:134-48. [PMID: 2651751 DOI: 10.1038/ki.1989.18] [Cited by in Crossref: 275] [Cited by in F6Publishing: 217] [Article Influence: 8.3] [Reference Citation Analysis]
2 Eschbach JW. The history of renal anaemia (anaemia and erythropoietin). Nephrology 1998;4:279-87. [DOI: 10.1111/j.1440-1797.1998.tb00360.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
3 Eckardt K. Anaemia correction—does the mode of dialysis matter? Nephrology Dialysis Transplantation 2000;15:1278-80. [DOI: 10.1093/ndt/15.9.1278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Slomka T, Lennon ES, Akbar H, Gosmanova EO, Bhattacharya SK, Oliphant CS, Khouzam RN. Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal Disease. The American Journal of the Medical Sciences 2016;351:309-16. [DOI: 10.1016/j.amjms.2015.12.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
5 Nielsen OJ. Recombinant human erythropoietin: experimental and clinical applications. Scandinavian Journal of Clinical and Laboratory Investigation 2018;51:1-10. [DOI: 10.1080/00365513.1991.11978682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Horina JH, Schmid CR, Roob JM, Winkler HM, Samitz MA, Hammer HF, Pogglitsch H, Krejs GJ. Bone marrow changes following treatment of renal anemia with erythropoietin. Kidney International 1991;40:917-22. [DOI: 10.1038/ki.1991.294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
7 Hino M, Miyazono K, Urabe A, Takaku F. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo. The International Journal of Cell Cloning 1989;7:257-63. [DOI: 10.1002/stem.5530070407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Mittal A, Singh V, Chowdhary S, Moideen A, Kumar D, Maniar K, Bhattacharyya R, Banerjee D. The Effect of Recombinant Human Erythropoietin on Bacterial Growth: A Dual-Edged Sword. Kidney Dis (Basel) 2019;5:81-90. [PMID: 31001539 DOI: 10.1159/000493684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Mcadams TA, Miller WM, Papoutsakis ET. pH is a potent modulator of erythroid differentiation: pH modulates Erythroid Differentiation. British Journal of Haematology 1998;103:317-25. [DOI: 10.1046/j.1365-2141.1998.00975.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
10 Chuengsaman P, Narenpitak S, Sritippayawan S. Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. World J Nephrol 2021; 10(6): 109-121 [PMID: 34909408 DOI: 10.5527/wjn.v10.i6.109] [Reference Citation Analysis]
11 Yoshida K, Yoneda T, Kimura S, Fujimoto K, Okajima E, Hirao Y. Polyamines as an Inhibitor on Erythropoiesis of Hemodialysis Patients by In Vitro Bioassay Using the Fetal Mouse Liver Assay. Therapher Dial 2006;10:267-72. [DOI: 10.1111/j.1744-9987.2006.00370.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
12 Erslev AJ. Clinical erythrokinetics: a critical review. Blood Rev 1997;11:160-7. [PMID: 9370047 DOI: 10.1016/s0268-960x(97)90011-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
13 Eschbach JW. Hematological Problems of Dialysis Patients. In: Maher JF, editor. Replacement of Renal Function by Dialysis. Dordrecht: Springer Netherlands; 1989. pp. 851-64. [DOI: 10.1007/978-94-009-1087-4_40] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
14 Kalantar-Zadeh K, Höffken B, Wünsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 1995;26:292-9. [PMID: 7645533 DOI: 10.1016/0272-6386(95)90649-5] [Cited by in Crossref: 130] [Cited by in F6Publishing: 103] [Article Influence: 4.8] [Reference Citation Analysis]
15 Nakao K, Wada J, Ota K, Ichikawa H, Akagi S, Okamoto A, Hida K, Nagake Y, Makino H. Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients. American Journal of Kidney Diseases 2003;41:624-36. [DOI: 10.1053/ajkd.2003.50124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
16 Korte W, Cogliatti SB, Jung K, Riesen W. Mild renal dysfunction is sufficient to induce erythropoietin deficiency in patients with unexplained anaemia. Clin Chim Acta 2000;292:149-54. [PMID: 10686284 DOI: 10.1016/s0009-8981(99)00213-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Yagihashi S, Watanabe K, Nagai K, Okudaira M. Pulmonary mucormycosis presenting as massive fatal hemoptysis in a hemodialytic patient with chronic renal failure. Klin Wochenschr 1991;69:224-7. [DOI: 10.1007/bf01646947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Tonelli M, Blake PG, Muirhead N. Predictors of erythropoietin responsiveness in chronic hemodialysis patients. ASAIO J 2001;47:82-5. [PMID: 11199321 DOI: 10.1097/00002480-200101000-00017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
19 Randall G, Meyer J, Swanepoel C, Jacobs P. Burst‐promoting activity in the serum of patients with chronic renal failure undergoing long‐term hemodialysis. Stem Cells 1993;11:428-34. [DOI: 10.1002/stem.5530110510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
20 Nangaku M, Eckardt KU. Pathogenesis of renal anemia. Semin Nephrol 2006;26:261-8. [PMID: 16949463 DOI: 10.1016/j.semnephrol.2006.06.001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 7.1] [Reference Citation Analysis]
21 Drechsel H, Metzger J, Freund S, Jung G, Boelaert JR, Winkelmann G. Rhizoferrin ? a novel siderophore from the fungusRhizopus microsporus var.rhizopodiformis. Biol Metals 1991;4:238-43. [DOI: 10.1007/bf01141187] [Cited by in Crossref: 53] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
22 Göbel V, Hoffmann HG, Müller-Wiefel DE, Braun A, Ludwig R, Schärer K, Debatin KM. Circulating haematopoietic progenitors during treatment of renal anaemia with recombinant human erythropoietin. Eur J Pediatr 1994;153:43-8. [PMID: 8313924 DOI: 10.1007/BF02000786] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
23 Eschbach JW, Haley NR, Egrie JC, Adamson JW. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Kidney International 1992;42:407-16. [DOI: 10.1038/ki.1992.302] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]